D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ODT holding history
Odonate Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ODT overviewAll 13F holders of ODTFull Q2 2026 holdings
- Shares (Q1 2022)
- 0
- Sold out in Q1 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2022 | 0 | $0 | 0.0% | −374,195−100.0% | Sold out | Holders |
| Q4 2021 | 374,195 | $505.0K | <0.1% | +140,855+60.4% | Added | Holders |
| Q3 2021 | 233,340 | $679.0K | <0.1% | −106,728−31.4% | Reduced | Holders |
| Q2 2021 | 340,068 | $1.19M | <0.1% | +39,236+13.0% | Added | Holders |
| Q1 2021 | 300,832 | $1.03M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.